Evidence map›Paper›PMID 23482462›Full record

ArticleInvestigative ophthalmology & visual science2013

Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells.

Atsuko Fujii, Ayumi Morimoto-Tochigi, Ryan D Walkup, Thomas R Shearer, Mitsuyoshi Azuma

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06854393 (Lacripep, a Novel Investigational Agent, for Corneal Wound Healing and Ocular Surface Homeostasis), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06854393 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Lacripep, a Novel Investigational Agent, for Corneal Wound Healing and Ocular Surface Homeostasis

TypeinterventionalSponsorHenry M. Jackson Foundation for the Advancement of Military MedicineRan2025 to 2027Enrolled88ConditionsCorneal Epithelial Wound HealingArms0.00025% Lacripep ophthalmic solution and Placebo
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Autophagy in the normal and diseased cornea.Experimental eye research · 2022
    Review
  2. Article
  3. The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.Advances in experimental medicine and biology · 2020
    Review
  4. Article
  5. Article
  6. Review
  7. A thermo-responsive protein treatment for dry eyes.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  8. Article
  9. Dry eye in LASIK patients.BMC research notes · 2014
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Atsuko FujiiSenju Laboratory of Ocular Sciences, Senju Pharmaceutical Corporation Limited, Beaverton, Oregon 97006, USA.
Ayumi Morimoto-Tochigi
Ryan D Walkup
Thomas R Shearer
Mitsuyoshi Azuma
Oregon Health & Science University · USSenju Pharmaceutical (United States) · USSenju Pharmaceutical (Japan) · JP

Funding

YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI FRUH, KLAUS J · 1985 to 2011
$140.8M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrew Haertel, Lauren Drew Martin · 2013 to 2026
$6.0M
Laser Scanning Confocal MicroscopeS10RR024585 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI CORNEA, ANDA N. · 2008 to 2008
$443k
NCRR NIH HHS P51 RR000163NCRR NIH HHS S10 RR024585NIH HHS U42 OD010426
6 · The paper itself

Abstract

purposeDuring inflammation of the ocular surface, increased proinflammatory cytokines depress tear protein secretion, suggesting that a decline in lacrimal cell function contributes to dry eye. Lacritin, a glycoprotein secreted from lacrimal acinar cells, may function as an autocrine factor to stimulate tear protein secretion. The purpose of the present experiment was to investigate lacritin-induced protein secretion in normal and cytokine-pretreated (inflammation model) monkey acinar cells.

methodsAcinar cells from monkey lacrimal glands were cultured with or without tumor necrosis factor alpha (TNF-α) plus interferon gamma (IFN-γ). Protein secretion was induced by lacritin or carbachol (Cch, positive control). Proteins were detected and identified by immunoblotting and immunocytochemistry. Intracellular Ca(2+) was measured with the fluorophore Calcium-4, and cell damage was determined by LDH leakage into the culture medium.

resultsIn cultured monkey acinar cells, lacritin stimulated tear protein secretion in normal cells without elevating intracellular Ca(2+). In contrast, Cch elevated intracellular Ca(2+) and release of tear proteins. This contrast suggested an alternate, calcium-independent mechanism for lacritin-induced protein secretion. TNF-α plus IFN-γ caused LDH leakage from sensitive human corneal epithelial cells, but even higher doses of TNF-α plus IFN-γ did not cause LDH leakage from monkey acinar cells, suggesting a higher tolerance against these cytokines. In cytokine-treated acinar cells, lacritin stimulated protein secretion as much as that in normal cells. In contrast, Cch-induced elevation of Ca(2+) and release of proteins were depressed by cytokines.

conclusionsLacritin might be a useful biotechnology-based treatment agent against ocular surface diseases where endogenous lacritin is inadequate.

Indexed as

Acinar CellsAnimalsCalciumCarbacholCells, CulturedDose-Response Relationship, DrugElectrophoresis, Polyacrylamide GelEye ProteinsGlycoproteinsImmunoblottingImmunohistochemistryInterferon-gammaLacrimal ApparatusLactoferrinLipocalinsL-Lactate DehydrogenaseCalciumCarbacholEye ProteinsGlycoproteinsInterferon-gammaLACRT protein, humanLactoferrinLipocalinsL-Lactate Dehydrogenasetear proteinsTumor Necrosis Factor-alpha

Identifiers

PMID23482462
PMCPMC3626314
OpenAlexW2045646525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.